Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with minimally invasive esophagectomy.

G Collins1, E Johnson, T Kroshus

  • 1Department of Surgery, Virginia Piper Cancer Institute, Abbott Northwestern Hospital, 800 East 28th Street, Minneapolis, MN 55047, USA.

Surgical Endoscopy
|December 20, 2005
PubMed
Summary

Minimally invasive esophagectomy (MIE) offers a safe alternative to open surgery for esophageal cancer. Experienced teams can achieve good outcomes with MIE, though careful patient selection is crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.

HIV medicine·2020
Same author

Sexual risk and HIV testing disconnect in men who have sex with men (MSM) recruited to an online HIV self-testing trial.

HIV medicine·2020
Same author

Containing a measles outbreak in Minnesota, 2017: methods and challenges.

Perspectives in public health·2019
Same author

Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.

HIV medicine·2016
Same author

Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.

The Journal of antimicrobial chemotherapy·2015

Area of Science:

  • Surgical Oncology
  • Gastrointestinal Surgery
  • Minimally Invasive Surgery

Background:

  • Minimally invasive esophagectomy (MIE) is an emerging surgical approach for esophageal diseases.
  • This study investigates the feasibility and outcomes of MIE performed by experienced surgeons.

Purpose of the Study:

  • To evaluate the safety and efficacy of MIE in a cohort of patients with esophageal cancer.
  • To assess the learning curve and outcomes for surgeons transitioning from open to minimally invasive techniques.

Main Methods:

  • A retrospective review of 25 patients who underwent MIE for resectable esophageal cancer.
  • Data collected included operative details, length of stay, morbidity, mortality, and pathological outcomes.

Main Results:

Related Experiment Videos

  • MIE was successfully performed in 23 out of 25 patients, with a 4% operative mortality rate.
  • Major complications occurred in 32% of patients, with an anastomotic leak rate of 12% and stricture rate of 24%.

Conclusions:

  • Minimally invasive esophagectomy is a technically demanding but safe procedure when performed by experienced multidisciplinary teams.
  • Optimal patient selection and a specialized team are essential for successful MIE outcomes.